"instanceType","description","name","label","text","uuid:ID","id"
"Objective","Main objective","OBJ1","","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","e4c60d9d-5101-4681-9f81-50ab715a6e90","Objective_1"
"Objective","Safety","OBJ2","","To document the safety profile of the xanomeline TTS.","0221c2a2-8a4c-4795-a812-573c2a3d90e4","Objective_2"
"Objective","Behaviour","OBJ3","","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","3ad839e4-9843-47d0-993c-4c2ea84cc18a","Objective_3"
